These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29024404)

  • 1. Removal of Sacral Nerve Stimulation Devices for Magnetic Resonance Imaging: What Happens Next?
    Lloyd JC; Gill BC; Pizarro-Berdichevsky J; Goldman HB
    Neuromodulation; 2017 Dec; 20(8):836-840. PubMed ID: 29024404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacral Neuromodulation for Genitourinary Problems.
    Banakhar M; Hassouna M
    Prog Neurol Surg; 2015; 29():192-9. PubMed ID: 26394134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis.
    Rensing AJ; Szymanski KM; Dunn S; King S; Cain MP; Whittam BM
    J Pediatr Urol; 2019 Feb; 15(1):39.e1-39.e6. PubMed ID: 30473473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral neuromodulation in patients with congenital faecal incontinence. Special issues and review of the literature.
    Lagares-Tena L; Millán-Paredes L; Lázaro-García L; Navarro-Luna A; Delgado-Rivilla S; Muñoz-Duyos A
    Tech Coloproctol; 2018 Feb; 22(2):89-95. PubMed ID: 29340832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
    Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device outcomes in pediatric sacral neuromodulation: A single center series of 187 patients.
    Boswell TC; Hollatz P; Hutcheson JC; Vandersteen DR; Reinberg YE
    J Pediatr Urol; 2021 Feb; 17(1):72.e1-72.e7. PubMed ID: 33129672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study.
    Kaaki B; Gupta D
    PLoS One; 2020; 15(7):e0235961. PubMed ID: 32645082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
    Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W
    Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of Sacral Neuromodulation Devices Is an Office Procedure.
    Martin S; Goldman HB
    Urology; 2023 Jul; 177():65-68. PubMed ID: 37030577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral neuromodulation for fecal incontinence in Latin America: initial results of a multicenter study.
    Oliveira L; Hagerman G; Torres ML; Lumi CM; Siachoque JAC; Reyes JC; Perez-Aguirre J; Sanchez-Robles JC; Guerrero-Guerrero VH; Regadas SM; Filho VG; Rosato G; Vieira E; Marzan L; Lima D; Londoño-Schimmer E; Wexner SD
    Tech Coloproctol; 2019 Jun; 23(6):545-550. PubMed ID: 31190233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Functional Outcomes of S3 Sacral Neuromodulation for the Treatment of Idiopathic Overactive Bladder.
    Ismail S; Chartier-Kastler E; Perrouin-Verbe MA; Rose-Dite-Modestine J; Denys P; Phé V
    Neuromodulation; 2017 Dec; 20(8):825-829. PubMed ID: 28967986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23-year experience.
    Gandhi S; Gajewski JB; Koziarz A; Almutairi S; Ali A; Cox A
    Neurourol Urodyn; 2021 Jan; 40(1):461-469. PubMed ID: 33232534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder.
    Zillioux J; Lewis KC; Hettel D; Goldman HB; Vasavada SP; Gill BC
    Neurourol Urodyn; 2023 Mar; 42(3):623-630. PubMed ID: 36701189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
    Benson K; McCrery R; Taylor C; Padron O; Blok B; de Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman H; Lane F
    Neurourol Urodyn; 2020 Jun; 39(5):1482-1488. PubMed ID: 32339339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Sacral Neuromodulation in Patients With Underlying Neurologic Lower Urinary Tract Dysfunction and Fecal Incontinence.
    Schwarztuch Gildor O; Neheman A; Vainrib M
    Urology; 2024 Jun; 188():54-62. PubMed ID: 38417466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation.
    Starkman JS; Duffy JW; Wolter CE; Kaufman MR; Scarpero HM; Dmochowski RR
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Feb; 19(2):277-82. PubMed ID: 17671752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment.
    Hoag N; Plagakis S; Pillay S; Edwards AW; Gani J
    Neurourol Urodyn; 2017 Jun; 36(5):1377-1381. PubMed ID: 27612039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?
    Gamé X; Ruffion A; Cornu JN; Phé V; Peyronnet B; Perrouin-Verbe MA; Aublant C; Adé A; Chartier-Kastler E
    Prog Urol; 2022 Sep; 32(10):672-680. PubMed ID: 35752523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral Neuromodulation: Standardized Electrode Placement Technique.
    Matzel KE; Chartier-Kastler E; Knowles CH; Lehur PA; Muñoz-Duyos A; Ratto C; Rydningen MB; Sørensen M; van Kerrebroeck P; de Wachter S
    Neuromodulation; 2017 Dec; 20(8):816-824. PubMed ID: 28975677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.